Blog

Indoco Remedies Q2 Review: A Mixed Bag for Investors Indoco Remedies Ltd., a leading Indian pharmaceutical company, recently announced its Q2 FY26 earnings, which came in above estimates. However, despite the positive earnings surprise, Dolat Capital has downgraded its Ebitda estimates and maintained a ‘Sell’ rating with a revised target price of Rs 224. Q2 […]

Nifty Consolidates Ahead of Major Earnings The Indian stock market witnessed a volatile session today, with the NSE Nifty 50 rebounding from its day’s lows to hold the 25,500 level, while the BSE Sensex slipped nearly 100 points. The Nifty Metal index emerged as the top-performing sector, while the Nifty IT index became the worst-performing

P&G Hygiene and Healthcare Ltd. Q2 Review: Key Highlights and Takeaways P&G Hygiene and Healthcare Ltd., a leading player in the Indian hygiene and healthcare sector, recently announced its Q2 results. The company’s performance was marred by weak gross margins, which had a significant impact on its profitability. In this article, we will delve into

Nykaa Q2 Results: A Comprehensive Analysis FSN E-Commerce Ventures Ltd., commonly known as Nykaa, has released its Q2 results for FY26, and the numbers are impressive. The company has reported a net profit of Rs 34.4 crore, which is a threefold increase from the Rs 10 crore reported in the year-ago period. Revenue has also

NCC Q2 Results: A Mixed Bag for Investors NCC Ltd., one of India’s leading construction companies, has reported its Q2 results, which have been impacted by execution delays and working capital strain. The company’s consolidated revenue declined 12% year-over-year (YoY) to Rs 45.8 billion, compared to Rs 52.2 billion in Q2 FY25. Execution Headwinds Weigh

India’s Week of Wins: A Review of the Top News India’s Women’s team created history by winning the World Cup, and the country’s stock market also witnessed a week of wins with earnings beats, bullish brokerages, and positive economic indicators. In this article, we will review the top news from the week and provide insights

Piramal Pharma Q2 Results Review: Key Takeaways for Investors Motilal Oswal has maintained its ‘Buy’ rating on Piramal Pharma Ltd. despite the company facing near-term headwinds. In this article, we will delve into the key takeaways from the Q2 results and analyze the factors that are expected to impact the company’s performance in the coming

Bajaj Auto Q2 Results: A Comprehensive Analysis Bajaj Auto Ltd.’s net profit for the second quarter of fiscal year 2026 rose 23.7% year-on-year, according to an exchange filing on Friday. The company reported a standalone bottom-line of Rs 2,480 crore as against Rs 2,005 crore in the year-ago period. This is in line with the

India’s Market Rally Stalled by AI and Geopolitics: Expert Insights A combination of artificial intelligence (AI) and global economics has stalled India’s progress amongst its emerging market peers, according to Ruchir Sharma, head of Rockefeller Capital Management’s international business, while speaking to NDTV’s Editor-In-Chief Rahul Kanwal. India’s Equity Remains ‘Emerging’ India’s equity remains ’emerging’ versus

Gold Prices Surge As US Economic Concerns Intensify Amid Shutdown Gold prices have seen a significant surge in recent days as concerns over the US economy have intensified, particularly in light of the ongoing shutdown. This trend is being closely watched by Indian investors, who are keen to understand how these global developments might impact